Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Generation of Induced Pluripotent Stem (iPS) Cell Lines From Skin Fibroblast Cells of Participants With Age-Related Macular Degeneration: An Ancillary Study to the Age-Related Eye Disease Study-2 (AREDS2)

NCT03372746 is registered in ClinicalTrials.gov with National Eye Institute (NEI) as lead sponsor.

NCT NCT03372746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03372746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Generation of Induced Pluripotent Stem (iPS) Cell Lines From Skin Fibroblast Cells of Participants With Age-Related Macular Degeneration: An Ancillary Study to the Age-Related Eye Disease Study-2 (AREDS2)
Lead sponsor
National Eye Institute (NEI)
Phase
Observational
Overall status
Completed
Start date
May 23, 2018
Completion date
March 21, 2019
Enrollment
187 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

amd